Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
14%
Active Surveillance
100%
Active Treatment
28%
Bivariate Regression
14%
Cancer Surveillance
100%
Data-limited
14%
Expectant Management
14%
Hazard Ratio
14%
Indolent Prostate Cancer
14%
Localized Prostate Cancer
14%
Medicare Data
14%
Office Visits
28%
Overtreatment
14%
Patients with Prostate Cancer
14%
Population-based
100%
Prostate Biopsy
14%
Prostate Cancer
100%
Prostate-specific Antigen Testing
28%
Regression Analysis
14%
Surveillance Epidemiology
14%
Surveillance Quality
14%
Surveillance Strategy
28%
Watchful Waiting
71%
Year of Diagnosis
14%
Medicine and Dentistry
Active Treatment
33%
Cancer Epidemiology
100%
Decision Making
16%
Hazard Ratio
16%
Medicare
16%
Overdiagnosis
16%
Prostate Biopsy
16%
Prostate Cancer
100%
Prostate Specific Antigen
16%
Prostate Specific Antigen Test
16%
Regression Analysis
16%
Surveillance, Epidemiology, and End Results
16%
Watchful Waiting
83%
Nursing and Health Professions
Ambulatory Care
33%
Cancer Epidemiology
100%
Confidence Interval
16%
Decision-Making
16%
Epidemiology
16%
Hazard Ratio
16%
Medicare
16%
Prostate Biopsy
16%
Prostate Cancer
100%
Prostate Specific Antigen
33%
Regression Analysis
16%
Watchful Waiting
83%